OBJECTIVES: This study sought to investigate the incidence, risk factors, and prognosis of dilated-hypokinetic evolution in a large cohort of patients with hypertrophic cardiomyopathy (HCM) followed up at a cardiology center serving both the pediatric and the adult population. BACKGROUND: The available data on this evolution of HCM mainly regards prevalence (rather than incidence) in adults, with very little being known about the pediatric population. METHODS: A total of 222 consecutive HCM patients (65% men, 19% < or =18 years old) were prospectively evaluated for a mean follow-up of 11 +/- 9 years. RESULTS: A diagnosis of dilated-hypokinetic HCM was made in 12 patients at first evaluation (11 without previous septal myectomy surgery; prevalence, 4.9%). Twelve of the 210 patients with classic HCM at first evaluation underwent dilated-hypokinetic evolution (incidence, 5.3/1,000 patient-years). Patients with prevalent/incident dilated-hypokinetic evolution were younger at first evaluation (32 +/- 14 years vs. 41 +/- 21 years, p = 0.04) and more often had a family history of HCM (61% vs. 26%, p = 0.002) or sudden death (43% vs. 19%, p = 0.01) with respect to patients who maintained classic HCM. Moreover, they showed greater interventricular septum (23 +/- 3 mm vs. 19 +/- 6 mm, p = 0.004) and posterior wall (15 +/- 3 mm vs. 13 +/- 4 mm, p = 0.006) thickness. Cardiovascular death-free survival was lower among patients with dilated-hypokinetic HCM (p < 0.04). Cox proportional hazards regression analysis identified left ventricular wall thickness (hazard ratio [HR] = 1.07; 95% confidence interval [CI], 1.01 to 1.14; p = 0.03) and end-diastolic diameter (HR = 1.08; 95% CI 1.04 to 1.11; p = 0.0001) as independent predictors of cardiovascular death. CONCLUSIONS: Dilated-hypokinetic evolution is rare but not exceptional in HCM. Young age at diagnosis, family history of HCM, and greater wall thickness are incremental risk factors for dilated-hypokinetic HCM, which carries an ominous prognosis.
Dilated-Hypokinetic evolution of hypertrophic cardiomyopathy / Biagini, E; Coccolo, F; Ferlito, M; Perugini, E; Rocchi, G; Bacchi Reggiani, L; Lofiego, C; Boriani, Giuseppe; Prandstraller, D; Picchio, Fm; Branzi, A; Rapezzi, C.. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - 46:8(2005), pp. 1543-1550.
|Data di pubblicazione:||2005|
|Titolo:||Dilated-Hypokinetic evolution of hypertrophic cardiomyopathy|
|Autore/i:||Biagini, E; Coccolo, F; Ferlito, M; Perugini, E; Rocchi, G; Bacchi Reggiani, L; Lofiego, C; Boriani, Giuseppe; Prandstraller, D; Picchio, Fm; Branzi, A; Rapezzi, C.|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.jacc.2005.04.062|
|Codice identificativo ISI:||WOS:000232579400021|
|Codice identificativo Scopus:||2-s2.0-26844513376|
|Codice identificativo Pubmed:||16226182|
|Citazione:||Dilated-Hypokinetic evolution of hypertrophic cardiomyopathy / Biagini, E; Coccolo, F; Ferlito, M; Perugini, E; Rocchi, G; Bacchi Reggiani, L; Lofiego, C; Boriani, Giuseppe; Prandstraller, D; Picchio, Fm; Branzi, A; Rapezzi, C.. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - 46:8(2005), pp. 1543-1550.|
|Tipologia||Articolo su rivista|
File in questo prodotto:
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris